PSA and prostate cancer

More research is not needed

BMJ 2009; 339 doi: 10.1136/sbmj.b5336 (Published 9 December 2009)
Cite this as: BMJ 2009;339:

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Charles J Wright, consultant in medical and academic affairs, programme planning, and evaluation1
  1. 1Suite 704, 211 St Patrick Street, Toronto, ON, Canada M5T 2Y9
  1. cjwright{at}rogers.com

    The conclusions of the editorial on prostate specific antigen for detecting early prostate cancer published with the paper and analysis article are incongruous.1 2 3 Having summarised all the evidence to date on the validity of screening using prostate specific antigen, the conclusions seemingly ignore most of it and call for more research.

    The more time we spend conducting more research the more …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL